
PGHH Q2 PAT Down 7% to ₹196 Cr on Cost Headwinds
Procter & Gamble Hygiene and Health Care Ltd. (PGHH) announced its second quarter results for the period ended September 30, 2026. Sales remained flat at ₹1145 crores compared to the previous year. Profit After Tax (PAT) saw a decline of 7% to ₹196 crores, primarily due to commodity cost fluctuations, rising raw material and energy costs, and unfavorable foreign exchange rates. These impacts were partially offset by productivity improvements. The company continued to invest in innovation and advertising & promotion to drive long-term competitiveness. For the first half of FY 2026-27, PGHH launched upgraded Vicks products and focused on its Whisper Period Pants. The company reiterated its confidence in its Integrated Growth Strategy.
Key Highlights
- Q2 sales flat at ₹1145 Cr; PAT down 7% to ₹196 Cr.
- Profitability impacted by commodity costs and forex headwinds.
- Company continued strategic investments in innovation and A&P.
- Launched upgraded Vicks products and focused on Whisper Period Pants.
- Management confident in Integrated Growth Strategy for long-term value.
Price Impact
More from PGHH